Alzheimer’s Disease Brain Scans | What The Images Show

Brain imaging can rule out other causes of memory change and, with certain PET tracers, show amyloid or tau that’s tied to Alzheimer’s.

A brain scan can feel like the moment everything gets answered. In real life, it’s a tool with limits. Some scans check for bleeding or stroke. Others measure shrinkage patterns. A few can show protein build-up linked with Alzheimer’s.

This guide keeps it practical: what each scan is built to show, what common report lines mean, and which questions help you leave a follow-up visit with a clear next step.

What Brain Imaging Adds To An Alzheimer’s Evaluation

Most clinicians start with symptoms, history, an exam, medication review, and cognitive testing. Imaging usually answers two questions: “Is something else causing this?” and “Do the brain changes fit a dementia pattern?”

The National Institute on Aging lists CT, MRI, and PET among the brain scans used in dementia workups, alongside other biomarkers that can help narrow the cause of cognitive decline. How biomarkers help diagnose dementia explains how imaging fits with other testing.

• Rule out problems that need different treatment, like a tumor, bleeding, hydrocephalus, or a new stroke.
• Show vascular injury that can stack on top of memory decline.
• Reveal atrophy patterns that can match certain dementia types.
• Show metabolism (FDG-PET) or protein burden (amyloid or tau PET) when the diagnosis is still uncertain.

Alzheimer’s Disease Brain Scans In Plain Terms

People say “a brain scan” as if it’s one test. It’s not. Each option answers a different question, and your clinician chooses based on what they need to confirm or rule out.

CT Scan

CT is fast and widely available. It can spot bleeding, larger strokes, masses, and fluid build-up. It can also show general brain shrinkage, yet it’s not as detailed as MRI for subtle atrophy patterns or smaller vascular changes. CT uses ionizing radiation, so it’s used when speed and access are worth that trade.

MRI

MRI gives sharper detail of brain structure and does not use ionizing radiation. It can show small strokes, white matter disease, and patterns of atrophy. If the clinician suspects a lesion or inflammation, MRI can change the plan quickly.

FDG-PET

FDG-PET measures how brain tissue uses glucose. Different dementias can produce different low-activity patterns. When symptoms overlap between Alzheimer’s and other disorders, FDG-PET can add a functional clue.

Amyloid PET

Amyloid PET uses a tracer that binds to beta-amyloid plaques. A negative scan suggests sparse to no plaques, which makes Alzheimer’s pathology less likely at the time of imaging. A positive scan means amyloid is present, yet amyloid can also appear in older adults without dementia.

The FDA prescribing information for AMYVID (florbetapir F 18) prescribing information describes intended use and interpretation of positive and negative amyloid scans.

Tau PET

Tau PET targets tau tangles. Tau distribution often tracks more closely with symptom stage than amyloid alone. Availability can be limited, and clinicians usually reserve it for cases where the result would change decisions.

PET/CT And PET/MR

Many PET studies are paired with CT or MRI in the same session. The CT or MRI helps line up tracer signal with anatomy. Seeing “PET/CT” on an order usually describes the machine setup, not a different tracer.

When A Clinician Orders Each Scan

Most memory evaluations start with structural imaging. If MRI is safe and available, it’s often the first pick. CT may be used when MRI isn’t an option or when time matters.

PET is more common when:

• Symptoms began at a younger age than expected for typical late-life patterns.
• The symptom picture is mixed, such as memory loss plus strong language change or movement issues.
• Testing is inconclusive, and a clearer answer would change treatment choices or planning.

RadiologyInfo, produced by radiology organizations (RSNA and ACR), outlines imaging used in evaluation and what patients can expect. Alzheimer’s Disease imaging overview gives a patient-friendly walkthrough of CT, MRI, and PET in this setting.

Scan Types Compared Side By Side

This table maps each scan to the kind of answer it can offer. Use it to follow the logic behind an order and to shape better questions at follow-up.

Scan Type	What It Can Show	When It’s Often Used
CT head	Bleeding, larger strokes, masses, hydrocephalus; rough view of atrophy	Fast rule-out; when MRI is unavailable or unsafe
MRI structural	Small strokes, white matter disease, atrophy patterns, tumors	First-line structural study for many memory evaluations
MRI with contrast	Inflammation, tumors, vascular lesions with more detail	When symptoms or labs raise suspicion for a lesion
FDG-PET	Metabolic patterns that can differ across dementia types	When symptom patterns overlap and function may clarify type
Amyloid PET	Presence or absence of beta-amyloid plaque signal	When Alzheimer’s pathology needs confirmation or exclusion
Tau PET	Tau tangle distribution patterns	Specialty evaluation when the result would change choices
SPECT	Blood flow patterns; less common than PET in many centers	When PET is unavailable and functional imaging is still desired
PET/CT or PET/MR combo	PET tracer signal aligned with CT or MRI anatomy	Common setup for PET studies to aid localization

How To Get Ready For Scan Day

Your imaging center will give exact instructions. These are the basics that tend to matter most.

• MRI safety: Tell the staff about pacemakers, clips, implants, and any prior metal-in-eye injury.
• Contrast history: Share kidney issues and past contrast reactions before you arrive.
• Time planning: CT is often quick. MRI and PET can take longer, and PET includes a quiet uptake period.
• Claustrophobia: Tell the team early so they can plan comfort options or clinician-prescribed medication.
• FDG-PET: Ask how fasting and blood sugar targets apply if you have diabetes.

How To Read A Brain Scan Report Without Panic

Radiology reports are written for clinicians. Start with the “impression” section. That’s the summary your clinician will usually use to guide the next step.

Common CT And MRI Phrases

• “No acute intracranial abnormality”: No new bleeding, large stroke, or mass effect seen.
• “Generalized atrophy”: Broad shrinkage. Context matters: age, symptoms, and prior scans.
• “Hippocampal volume loss”: Shrinkage in a memory-related structure. It can fit Alzheimer’s patterns, but it’s not exclusive.
• “Chronic microvascular ischemic change”: Small-vessel disease linked with vascular risk factors and aging.
• “White matter hyperintensities”: MRI spots that often reflect small-vessel change; the grade and pattern matter.

What To Look For In PET Wording

Amyloid PET reports usually state “positive” or “negative.” FDG-PET reports often name regions of low activity and may say whether the pattern fits Alzheimer’s more than another cause.

Two follow-up questions that often help:

• Which scan finding best matches the symptoms and cognitive testing?
• What diagnoses moved down the list because of this scan?

What A Positive Amyloid Result Means In Real Life

A positive amyloid scan shows plaque signal. That can line up with Alzheimer’s pathology, but amyloid can also be present without dementia. It can also coexist with vascular brain injury.

A negative amyloid scan is often more decisive. Sparse to no amyloid plaque signal makes Alzheimer’s pathology less likely at that moment and pushes the clinician to re-check other causes of cognitive decline.

Clinical groups publish “appropriate use” criteria to match amyloid and tau PET to scenarios where results are most likely to change care. The Alzheimer’s Association has a summary of updated criteria here: updated appropriate use criteria for amyloid and tau PET.

Report Terms You Can Translate At Home

This table turns common phrases into plain language and gives a question that fits each one. Bring one or two prompts to the visit so you leave with a clean next step.

Report Term	Plain Meaning	Good Follow-Up Question
“Disproportionate temporal atrophy”	More shrinkage in temporal lobes than elsewhere	Does this match our symptom pattern and cognitive testing?
“Posterior parietal hypometabolism”	Lower glucose use in back/top brain regions	Does this pattern fit Alzheimer’s or another dementia type?
“Amyloid PET positive”	Amyloid plaque signal present in cortex	Given age and symptoms, how much weight should we place on this?
“Amyloid PET negative”	Sparse to no amyloid plaque signal	What other diagnoses rise after this result?
“Microhemorrhages”	Tiny prior bleeds, often tied to vessel disease	Does this change medication choices or fall-risk planning?
“Enlarged ventricles”	Brain fluid spaces larger than expected	Is this age-related atrophy, or is NPH on the table?

Questions That Keep The Follow-Up Visit Grounded

• What diagnosis fits best right now, and what’s still uncertain?
• Which scan finding carries the most weight for that diagnosis?
• What conditions did imaging help rule out?
• What test comes next, if any, and what would it change?

A Short Family Checklist

• Bring a symptom timeline: when changes began, what changed first, what has worsened.
• Bring a medication list, including sleep aids and allergy meds.
• Ask for the written report and access to the images if offered.
• Schedule the follow-up appointment before scan day when possible.

Brain scans don’t hand you a whole story on their own. Still, when you know what each scan is built to show, the process feels less mysterious and the next step is easier to choose.